Cita APA

Doi, T., Tajimi, M., Mori, J., Asou, H., Inoue, K., Benhadji, K. A., & Naito, Y. (2020). A phase 1 study of crenigacestat (LY3039478), the Notch inhibitor, in Japanese patients with advanced solid tumors. Invest New Drugs.

Chicago Style Citation

Doi, Toshihiko, Masaomi Tajimi, Joji Mori, Hiroya Asou, Koichi Inoue, Karim A. Benhadji, i Yoichi Naito. "A Phase 1 Study of Crenigacestat (LY3039478), the Notch Inhibitor, in Japanese Patients With Advanced Solid Tumors." Invest New Drugs 2020.

Cita MLA

Doi, Toshihiko, et al. "A Phase 1 Study of Crenigacestat (LY3039478), the Notch Inhibitor, in Japanese Patients With Advanced Solid Tumors." Invest New Drugs 2020.

Atenció: Aquestes cites poden no estar 100% correctes.